Baird Financial Group, Inc. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 222 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$925,000
+15.0%
4,729
-0.0%
0.00%0.0%
Q2 2020$804,000
+62.1%
4,731
+10.0%
0.00%
+50.0%
Q1 2020$496,000
+3.3%
4,300
+2.5%
0.00%0.0%
Q4 2019$480,000
+43.3%
4,197
+6.9%
0.00%
+100.0%
Q3 2019$335,000
+22.7%
3,925
-0.4%
0.00%0.0%
Q2 2019$273,000
-4.9%
3,942
+0.4%
0.00%
-50.0%
Q1 2019$287,000
-26.8%
3,925
-43.2%
0.00%
-33.3%
Q4 2018$392,000
-33.8%
6,915
-5.2%
0.00%
-25.0%
Q3 2018$592,000
+24.6%
7,294
+1.9%
0.00%
+33.3%
Q2 2018$475,000
+33.8%
7,155
+5.6%
0.00%
+50.0%
Q1 2018$355,000
-1.1%
6,775
+0.9%
0.00%
-33.3%
Q4 2017$359,000
+0.6%
6,712
+2.2%
0.00%0.0%
Q3 2017$357,000
-61.3%
6,565
-63.2%
0.00%
-57.1%
Q2 2017$922,000
-21.2%
17,816
-4.3%
0.01%
-22.2%
Q1 2017$1,170,000
-0.6%
18,608
-16.6%
0.01%
-10.0%
Q4 2016$1,177,000
-44.6%
22,313
-43.3%
0.01%
-47.4%
Q3 2016$2,126,000
+13.8%
39,358
-11.5%
0.02%
+11.8%
Q2 2016$1,868,000
+50.9%
44,469
+26.0%
0.02%
+41.7%
Q1 2016$1,238,000
+26.1%
35,279
+61.3%
0.01%
+20.0%
Q4 2015$982,000
+17.6%
21,874
+1.1%
0.01%
+11.1%
Q3 2015$835,000
-36.8%
21,646
-20.7%
0.01%
-30.8%
Q2 2015$1,321,00027,2960.01%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 19,322,947$846,925,00012.04%
CAPITAL GUARDIAN TRUST CO 6,585,072$288,624,0002.00%
PINNACLE ASSOCIATES LTD 1,521,388$66,682,0001.38%
CAPITAL INTERNATIONAL LTD /CA/ 477,400$20,924,0001.37%
USS Investment Management Ltd 1,658,954$72,712,0001.36%
COLUMBIA WANGER ASSET MANAGEMENT LLC 7,547,000$330,785,0001.33%
Baillie Gifford 9,811,312$430,030,0001.09%
Princeton Portfolio Strategies Group LLC 32,800$1,438,0001.06%
ROCKEFELLER FINANCIAL SERVICES INC 1,028,318$45,072,0001.05%
WASATCH ADVISORS LP 2,148,869$94,185,0000.98%
View complete list of SEATTLE GENETICS INC shareholders